Terahertz time-domain spectroscopy of glioma patient blood plasma: Diagnosis and treatment

doi:10.3390/app13095434

Эндаумент фонд ТГУ!
Впиши своё имя в историю университета
- Сделать пожертвование -

Add to "Quick Collection"

Description	Size	Format
Terahertz time-domain spectroscopy of glioma patient blood plasma: Diagnosis and treatment	4 MB	Adobe Acrobat PDF	Read	Download
DOI Доступ к ресурсу на сайте издателя			10.3390/app13095434

#терагерцовая спектроскопия во временной области

#машинное обучение

#глиома

#плазма крови человека

#машины опорных векторов

#случайный лес, алгоритм машинного обучения

#экстремальное повышение градиента

Title: Terahertz time-domain spectroscopy of glioma patient blood plasma: Diagnosis and treatment
Creator: Cherkasova, Olga P.
|
Vrazhnov, Denis A.
|
Knyazkova, Anastasia I.
|
Konnikova, Maria R.
|
Stupak, Evgeny
|
Glotov, Vadim
|
Stupak, Vyacheslav
|
Nikolaev, Nazar
|
Paulish, Andrey
|
Peng, Yan
|
Kistenev, Yury V.
|
Shkurinov, Alexander P.
Date: 2023
DOI: 10.3390/app13095434
Description: Gliomas, one of the most severe malignant tumors of the central nervous system, have a high mortality rate and an increased risk of recurrence. Therefore, early glioma diagnosis and the control of treatment have great significance. The blood plasma samples of glioma patients, patients with skull craniectomy defects, and healthy donors were studied using terahertz time-domain spectroscopy (THz-TDS). An analysis of experimental THz data was performed by machine learning (ML). The ML pipeline included (i) THz spectra smoothing using the Savitzky–Golay filter, (ii) dimension reduction with principal component analysis and t-distribution stochastic neighborhood embedding methods; (iii) data separability analyzed using Support Vector Machine (SVM), Random Forest (RF), and Extreme Gradient Boosting (XGBoost). The ML models’ performance was evaluated by a k-fold cross validation technique using ROC-AUC, sensitivity, and specificity metrics. It was shown that tree-based ensemble methods work more accurately than SVM. RF and XGBoost provided a better differentiation of the group of patients with glioma from healthy donors and patients with skull craniectomy defects. THz-TDS combined with ML was shown to make it possible to separate the blood plasma of patients before and after tumor removal surgery (AUC = 0.92). Thus, the applicability of THz-TDS and ML for the diagnosis of glioma and treatment monitoring has been shown